Medplus Health Services (NSE:MEDPLUS) Tariff Resilience Score: 0/10 (As of Jul. 19, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MEDPLUS Medplus Health Services Ltd NSE:MEDPLUS
78 GF Score
Price ₹801.10
GF Value ₹961.24
Valuation Modestly Undervalued
View Full Analysis

What is Medplus Health Services Tariff Resilience Score?

Medplus Health Services has the Tariff Resilience Score of 0, which implies that the company might have .

Medplus Health Services has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Medplus Health Services might have .

Medplus Health Services  (NSE:MEDPLUS) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Medplus Health Services Tariff Resilience Score Related Terms

NSE:MEDPLUS
78GF Score
Medplus Health Services Ltd NSE:MEDPLUS
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Medplus Health Services (NSE:MEDPLUS) Overvalued in 2026?

Based on GuruFocus' analysis, Medplus Health Services stock appears to be undervalued. The current stock price of ₹801.10 is trading 16.7% below its estimated GF Value™ of ₹961.24. GuruFocus considers Medplus Health Services to be Modestly Undervalued.

Key valuation signals for NSE:MEDPLUS:

  • Tariff Resilience Score: 0
  • GF Value™: ₹961.24 vs. price of ₹801.10 (16.7% below fair value)
  • GF Score™: 78/100

No single metric tells the full story. See the NSE:MEDPLUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medplus Health Services Business Description

Other Exchanges 543427:India
Address Opposite IDPL Railway Siding Road, Municipal No: 11-6-56, Survey No. 257 & 258/1, Moosapet, Kukatpally, Hyderabad, TG, IND, 500 037
Medplus Health Services Ltd is a pharmacy retailer. It offers pharmaceutical and wellness products such as medicines, vitamins, medical devices, test kits, and others. The company also offers an omnichannel platform wherein customers can purchase products through stores, place orders over the telephone, online orders, and a Click and Pick facility. Its operating segments include Retail, Diagnostics, and Others.
78GF Score

Get the complete analysis for NSE:MEDPLUS

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹801.10
Price
₹961.24
GF Value